Yet another major ivermectin clinical trial is just a couple weeks from initiation in Cali Colombia led by Dr. Eduardo Lopez sponsored by the Centro de Estudios en Infectogia Pediatrica—The Center for Clinical Research and Comprehensive Care of Infectious Diseases. TrialSite News was able to interview the investigator as he prepares for what will be an important clinical study assessing ivermectin in 400 adult patients with mild COVID-19: the study should start within two weeks or before the end of June 2020.
Ivermectin: The Wave
Since March, TrialSite News has been tracking the ivermectin wave in association with the COVID-19 pandemic. Starting with the initial pathbreaking lab research work accomplished by Monash University and the Peter Doherty Institute demonstrating that ivermectin literally zaps SARS-CoV-2 virus in a cell culture to the Broward Health Board approved, off-label observational study completed in Florida to the interview with a physican at Bangladesh Medical College who reported to TrialSite News in an interview that the results for a hospital approved, off-label of 60 COVID-19 patients study were “astounding.” Then there are the growing number of clinical...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).